BA1: Biological Age in Worksite Health Promotion

Sponsor
University of Copenhagen (Other)
Overall Status
Completed
CT.gov ID
NCT03529357
Collaborator
Metropolitan University College (Other), Technical University of Denmark (Other)
5,473
1
72
76

Study Details

Study Description

Brief Summary

This cohort study investigates how implementation of Biological Age technology in worksite health promotion, affects health behavior in the general Danish working population.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This cohort study is designed on the basis of Body Age tests, executed by a private Danish health care company in the period from 2010 to 2013.

    The dataset comprises pre- and post Body Age tests from >4000 individuals. They used a standardised protocol and educated staff ( physiotherapists or with a degree in sports science) to carry out the tests. Body Age tests apply biometrics, fitness level and health status data of the employee. The test results are characterized by a Body Age score, which defines the employee's biological age (in years).

    This design categorises as a register study why The Danish National Committee is not applied for.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    5473 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Implementation of Biological Age in Worksite Health Promotion - a Cohort Study on >4000 Danish Employees and Their Health Risk Reductions
    Actual Study Start Date :
    Jun 1, 2007
    Actual Primary Completion Date :
    Jun 1, 2013
    Actual Study Completion Date :
    Jun 1, 2013

    Outcome Measures

    Primary Outcome Measures

    1. Biological Age [The Biological Age is calculated at baseline and at one year follow up]

      An algorithm calculates Biological Age, using physiological parameters and biomarkers measured during the test.

    Secondary Outcome Measures

    1. BMI [Measured at baseline and at one year follow up]

      BodyMassIndex is a major risk factor for developing lifestyle related diseases.

    2. Bodyweight [Measured at baseline and at one year follow up]

      The weight in kilograms of each individual

    3. FM [Measured at baseline and at one year follow up]

      Fat Mass is important to look at isolated in reference to whole bodyweight

    4. FFM [Measured at baseline and at one year follow up]

      Fat Free Mass is important to look at isolated in reference to Whole bodyweight

    5. BP [Measured at baseline and at one year follow up]

      Bloodpressure as a result from systolic and diastolic bloodpressure

    6. VO2max [Measured at baseline and at one year follow up]

      Maximal Oxygen consumption

    7. BG [Measured at baseline and at one year follow up]

      Blood Glucose

    8. HDL [Measured at baseline and at one year follow up]

      High Density Lipoprotein

    9. LDL [Measured at baseline and at one year follow up]

      Low Density Lipoprotein

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Males and females interested in their personal health status

    • Participants who perform both baseline and follow up test.

    Exclusion Criteria:
    • Use of beta blockers

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Copenhagen, Department of Biomedical Sciences Copenhagen Denmark 2200

    Sponsors and Collaborators

    • University of Copenhagen
    • Metropolitan University College
    • Technical University of Denmark

    Investigators

    • Principal Investigator: Jørn W Helge, Prof., BMI, Xlab

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Jørn Wulff Helge, Ph.D., Proffesor Jørn Wulff Helge, University of Copenhagen
    ClinicalTrials.gov Identifier:
    NCT03529357
    Other Study ID Numbers:
    • BiologicalAge1
    First Posted:
    May 18, 2018
    Last Update Posted:
    May 22, 2018
    Last Verified:
    May 1, 2018
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Jørn Wulff Helge, Ph.D., Proffesor Jørn Wulff Helge, University of Copenhagen

    Study Results

    No Results Posted as of May 22, 2018